Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003235851 | SCV003932948 | uncertain significance | not provided | 2022-12-19 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ce |
RCV003235851 | SCV005330439 | uncertain significance | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | EP300: PP3 |
Prevention |
RCV004741474 | SCV005355482 | uncertain significance | EP300-related disorder | 2024-09-04 | no assertion criteria provided | clinical testing | The EP300 c.4118T>G variant is predicted to result in the amino acid substitution p.Phe1373Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0035% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |